" class="no-js "lang="en-US"> Benny Sorensen - Pharmtech Focus
Tuesday, January 31, 2023

Breaking News

MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors Bruno Ultra Barcelos is appointed Managing Director of Ethypharm UK Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform, Omni Pro 12 CHOP Experts Share Cutting-Edge Innovations at Arab Health Exhibition Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology ClariMed Launches Integrated Medical Device Services Partner
Benny Sorensen

Benny Sorensen

About Benny Sorensen

Experienced patient centric Biotechnology Executive with demonstrated translational research, early- intermediate- and late stage clinical development experience. Strong entrepreneurial profile and successful track record of building lean high-performing R&D organizations. Excellent presentation and discussion skills. Extensive pharma-, biotech- and clinical academic high profile network.

Related Story

Fundraising

 Novo Holdings Co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders | Pharmtech Focus

Novo Holdings Co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders

July 23 2021

Novo Holdings, a leading international life science investor, today announces that it has co-led alongside […]